XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Share Based Payment
12 Months Ended
Mar. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Share Based Payment
33)
SHARE BASED PAYMENT

Description of the share based payment arrangements

Share Option Programs (Equity-Settled)

 

a)
Share Incentive Plan
i)
Restricted Share Units (RSUs)

In 2010, the Group approved a share incentive plan in Mauritius, named the MakeMyTrip 2010 Share Incentive Plan (“Share Incentive Plan”). During the years ended March 31, 2022, 2023 and 2024, the Group granted restricted share units, or RSUs, under the plan to eligible employees. Each restricted share unit represents the right to receive one common share. The fair value of each restricted share unit is the market price of one common share of the Group on the date of grant.

Terms and Conditions of the RSUs

The terms and conditions relating to the RSUs grants under this Share Incentive Plan are given below:

 

Grant details

 

Number of
instruments

 

 

Vesting
conditions

 

Contractual
life of RSUs

RSUs granted during the year ended March 31, 2022

 

 

2,413,442

 

 

Refer notes

 

4 – 9 years

RSUs granted during the year ended March 31, 2023

 

 

1,455,554

 

 

Refer notes

 

4 – 8 years

RSUs granted during the year ended March 31, 2024

 

 

829,578

 

 

Refer notes

 

4 – 8 years

 

Notes:

Of the RSUs granted during the year ended March 31, 2024:

- Nil (March 31, 2023: Nil and March 31, 2022: 2,529) RSUs have graded vesting over 4 years: 10% on the expiry of 12 months from the grant date, 20% on the expiry of 24 months from the grant date, 30% on the expiry of 36 months from the grant date, 40% on the expiry of 48 months from the grant date.

- 571,784 (March 31, 2023: 1,120,117 and March 31, 2022: 1,072,635) RSUs have graded vesting over 4 years: 25% on the expiry of 12 months from the grant date, 25% on the expiry of 24 months from the grant date, 25% on the expiry of 36 months from the grant date, 25% on the expiry of 48 months from the grant date.

- Nil (March 31, 2023: Nil and March 31, 2022: 564,541) RSUs have graded vesting over 5 years: 20% on the expiry of 12 months from the grant date, 20% on the expiry of 24 months from the grant date, 20% on the expiry of 36 months from the grant date, 20% on the expiry of 48 months from the grant date, 20% on the expiry of 60 months from the grant date.

- Nil (March 31, 2023: Nil and March 31, 2022: 547,060) RSUs have 100% vesting on September 30, 2024, Nil (March 31, 2023: 335,274 and March 31, 2022: Nil) RSUs have 100% vesting on September 30, 2025 and 209,731(March 31, 2023: Nil and March 31, 2022: 225,816) RSUs have 100% vesting on September 30, 2026. Further, the Group's estimate of the number of shares to be issued is adjusted upward or downward based upon the probability of achievement of the factors like Group performance (revenue, profit and gross merchandise value) of next three financial years and service condition. Maximum shares the employees are eligible to receive under this scheme are 150% of the total RSUs granted.

- 48,063 (March 31, 2023: 163 and March 31, 2022: 861) RSUs were fully vested on the grant date.

- These RSUs can be exercised within a period of 48 months from the date of vesting or within a period of 6 months from the date of termination of employment, whichever is earlier.

 

The number and weighted average exercise price of RSUs under share incentive plan are as follows:

 

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

 

For the year ended March 31

 

Particulars

 

2022

 

 

2022

 

 

2023

 

 

2023

 

 

2024

 

 

2024

 

Outstanding at the beginning of the year

 

 

0.0005

 

 

 

5,979,731

 

 

 

0.0005

 

 

 

7,445,641

 

 

 

0.0005

 

 

 

7,773,744

 

Granted during the year

 

 

0.0005

 

 

 

2,413,442

 

 

 

0.0005

 

 

 

1,455,554

 

 

 

0.0005

 

 

 

829,578

 

Forfeited and expired during the year

 

 

0.0005

 

 

 

(424,405

)

 

 

0.0005

 

 

 

(369,630

)

 

 

0.0005

 

 

 

(178,993

)

Exercised during the year

 

 

0.0005

 

 

 

(523,127

)

 

 

0.0005

 

 

 

(757,821

)

 

 

0.0005

 

 

 

(3,383,113

)

Outstanding at the end of the year

 

 

0.0005

 

 

 

7,445,641

 

 

 

0.0005

 

 

 

7,773,744

 

 

 

0.0005

 

 

 

5,041,216

 

Exercisable at the end of the year

 

 

0.0005

 

 

 

3,869,396

 

 

 

0.0005

 

 

 

4,327,478

 

 

 

0.0005

 

 

 

2,234,132

 

 

The grant date fair value of RSUs granted during the year is in the range of USD 24.00 to USD 55.42 (March 31, 2023: USD 24.25 to USD 32.62 and March 31, 2022: USD 24.16 to USD 32.97).

The RSUs outstanding at March 31, 2024 have an exercise price per share of USD 0.0005 (March 31, 2023: USD 0.0005 and March 31, 2022: USD 0.0005) and a weighted average contractual life of 4.3 years (March 31, 2023: 3.9 years and March 31, 2022: 4.3 years).

During the year ended March 31, 2024, share based payment expense recognized under personnel expenses (refer note 13) amounted to USD 36,936 (March 31, 2023: USD 34,651 and March 31, 2022: USD 32,921) for the RSUs granted under the Share Incentive Plan.

ii) Employee Stock Options (ESOPs)

In 2010, the Group approved a share incentive plan in Mauritius, named the MakeMyTrip 2010 Share Incentive Plan (“Share Incentive Plan”). Each ESOP represents the right to receive one hundred common equity shares of the Group. No options were granted during the years ended March 31, 2022, 2023 and 2024, respectively.

The number and weighted average exercise price of ESOPs under share incentive plan are as follows:

 

 

 

Weighted
Average
Exercise
Price per
ESOP (USD)

 

 

Number
of
Awards

 

 

Weighted
Average
Exercise
Price per
ESOP (USD)

 

 

Number
of
Awards

 

 

Weighted
Average
Exercise
Price per
ESOP (USD)

 

 

Number
of
Awards

 

 

 

For the year ended March 31

 

Particulars

 

2022

 

 

2022

 

 

2023

 

 

2023

 

 

2024

 

 

2024

 

Outstanding at the beginning of the year

 

 

2,229

 

 

 

19,489

 

 

 

2,229

 

 

 

19,489

 

 

 

2,229

 

 

 

18,502

 

Forfeited and expired during the year

 

 

2,229

 

 

 

 

 

 

2,229

 

 

 

 

 

 

2,229

 

 

 

 

Exercised during the year

 

 

2,229

 

 

 

 

 

 

2,229

 

 

 

(987

)

 

 

2,229

 

 

 

(2,689

)

Outstanding at the end of the year

 

 

2,229

 

 

 

19,489

 

 

 

2,229

 

 

 

18,502

 

 

 

2,229

 

 

 

15,813

 

Exercisable at the end of the year

 

 

2,229

 

 

 

12,949

 

 

 

2,229

 

 

 

18,502

 

 

 

2,229

 

 

 

15,813

 

 

The ESOPs outstanding at March 31, 2024 have an exercise price per option of USD 2,229 (March 31, 2023: USD 2,229 and March 31, 2022: USD 2,229) and a weighted average contractual life of 1.4 years (March 31, 2023: 2.4 years and March 31, 2022: 3.4 years).

 

During the year ended March 31, 2024, share based payment expense recognized under personnel expenses (refer note 13) amounted to Nil (March 31, 2023: USD 966 and March 31, 2022: USD 3,724) for the ESOPs granted under the Share Incentive Plan.

b) Employee Stock Option Plan 2015 ("Simplotel Plan 2015")

Simplotel, one of the Group’s subsidiary (refer note 7 (c)), approved a share option plan in India, named the Employees Stock Option Plan 2015, hereinafter referred as "Simplotel Plan 2015" in the year ended March 31, 2015. During the year ended March 31, 2024, 192 Simplotel Employee Stock Options ("Simplotel ESOP") (March 31, 2023: Nil) were granted to employees. Each Simplotel ESOP represents the right to receive one equity share of Simplotel.

The number and weighted average exercise price of employee stock options under the ESOP Plan 2015 are as follows:

 

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

 

For the year ended March 31

 

 

For the year ended March 31

 

Particulars

 

2023

 

 

2023

 

 

2024

 

 

2024

 

Outstanding at beginning of the year

 

 

0.12

 

 

 

1,073

 

 

 

0.12

 

 

 

1,065

 

Granted during the year

 

 

 

 

 

 

 

 

0.12

 

 

 

192

 

Forfeited and expired during the year

 

 

 

 

 

(8

)

 

 

0.12

 

 

 

(55

)

Outstanding at the end of the year

 

 

0.12

 

 

 

1,065

 

 

 

0.12

 

 

 

1,202

 

Exercisable at the end of the year

 

 

0.12

 

 

 

947

 

 

 

0.12

 

 

 

949

 

 

 

 

 

 

 

 

 

 

Inputs for Measurement of Grant Date Fair Values of Simplotel ESOP Plan

 

 

 

For the year ended March 31, 2024

 

Fair value of ESOP and assumptions

 

 

 

Share price at grant date (USD)

 

 

442.90

 

Fair value at grant date (USD)

 

 

442.90

 

Exercise price (USD)

 

 

0.12

 

Expected volatility

 

 

46.50

%

Expected term

 

6 years

 

Expected dividends

 

 

 

Risk-free interest rate

 

 

7.60

%

 

192 Simplotel ESOPs have graded vesting over 4 years: 10% will vest on completion of one year from the grant date, remaining Simplotel ESOPs will equally vest quarterly thereafter in the remaining 3 years in the ratio 20% in second year, 30% in third year and 40% in fourth year from the date of grant.

 

The Simplotel ESOPs outstanding at March 31, 2024 have an exercise price per Simplotel ESOP of USD 0.12 (March 31, 2023: 0.12). The weighted average contractual life of the Simplotel ESOPs granted under this plan is 10 years.

 

During the year ended March 31, 2024, share based payment expense recognized under personnel expenses (refer note 13) amounted to USD 1 (March 31, 2023: USD 26), for the Simplotel ESOPs granted under Simplotel Plan 2015.

 

c) Book My Forex Employees Stock Option Plan, 2022 ("BMF Plan 2022")

 

BMF, one of the Group’s subsidiary (refer note 7 (b)), approved a plan in India, named the Book My Forex Employees Stock Option Plan, 2022, hereinafter referred as "BMF Plan 2022" in the year ended March 31, 2022. During the year ended March 31 2024, 2,490 BMF Employee Stock Options ("BMF ESOPs") (March 31, 2023: Nil) were granted to employees. Each BMF ESOP represents the right to receive one equity share of BMF.

 

The number and weighted average exercise price of BMF ESOPs under the BMF Plan 2022 are as follows:

 

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

 

For the year ended March 31

 

Particulars

 

2024

 

 

2024

 

Outstanding at beginning of the year

 

 

 

 

 

 

Granted during the year

 

 

0.12

 

 

 

2,490

 

Outstanding at the end of the year

 

 

0.12

 

 

 

2,490

 

Exercisable at the end of the year

 

 

 

 

 

 

 

Inputs for Measurement of Grant Date Fair Values of BMF Plan 2022

 

 

 

For the year ended March 31, 2024

 

Fair value of ESOP and assumptions

 

 

 

Share price at grant date (USD)

 

 

16.65

 

Fair value at grant date (USD)

 

 

16.65

 

Exercise price (USD)

 

 

0.12

 

Expected volatility

 

 

46.40

%

Expected term

 

6 years

 

Expected dividends

 

 

 

Risk-free interest rate

 

 

7.32

%

 

Notes:

Of the BMF ESOPs granted during the year ended March 31, 2024:

- 1,992 BMF ESOPs have graded vesting over 2 years: 50% will vest on completion of one year from the grant date and remaining 50% will vest on completion of two years from the grant date.

 

- 498 BMF ESOPs have graded vesting over 3 years: one third each will vest on completion of one, two and three years from the grant date respectively.

 

The BMF ESOPs outstanding at March 31, 2024 have an exercise price per BMF ESOP of USD 0.12. The weighted average contractual life of the BMF ESOPs granted under this plan is 10.6 years.

 

During the year ended March 31, 2024, share based payment expense recognized under personnel expenses (refer note 13) amounted to USD 26 for the BMF ESOPs granted under BMF Plan 2022.

 

d) 2013 Employee Stock Option Plan ("Savaari Plan 2013")

 

Savaari, one of the Group’s subsidiary (refer note 7 (d)), approved a share option plan in India, named the 2013 Employee Stock Option Plan, hereinafter referred as "Savaari Plan 2013" during the year ended March 31, 2013. Each Savaari ESOP represents the right to receive one equity share of Savaari. No Savaari ESOPs were granted during the year ended March 31, 2024.

 

The number and weighted average exercise price of Savaari ESOPs under the Savaari Plan 2013 are as follows:

 

 

 

Weighted
Average
Exercise
Price per
share (USD)

 

 

Number
of
Awards

 

 

 

For the Year ended March 31

 

Particulars

 

2024

 

 

2024

 

Outstanding at the date of acquisition (refer note 7 (d))

 

 

0.01

 

 

 

30,710

 

Forfeited and expired during the year

 

 

0.01

 

 

 

(25

)

Outstanding at the end of the year

 

 

0.01

 

 

 

30,685

 

Exercisable at the end of the year

 

 

0.01

 

 

 

30,637

 

The Savaari ESOPs outstanding at March 31, 2024 have an exercise price per Savaari ESOP of USD 0.01. The weighted average contractual life of the Savaari ESOPs granted under this plan is 6.1 years.

 

During the year ended March 31, 2024, share based payment expense recognized under personnel expenses (refer note 13) amounted to USD *, for the Savaari ESOPs granted under Savaari Plan 2013.

 

* less than 1